November 2, 2012 by Brian Chau
In an eagerly anticipated decision, the Supreme Court of Canada released its judgment on Canada v. GlaxoSmithKline Inc., 2012 SCC 52 (Glaxo SCC, affirming 2010 FCA 201 [Glaxo FCA]).
|
Canada v. GSK – Intellectual Property Rights and the Arm’s Length Principle
November 2, 2012 by Brian Chau In an eagerly anticipated decision, the Supreme Court of Canada released its judgment on Canada v. GlaxoSmithKline Inc., 2012 SCC 52 (Glaxo SCC, affirming 2010 FCA 201 [Glaxo FCA]).
Re-examination vs. Invalidity Proceedings: A Question of Judicial Supremacy
August 5, 2012 by Brian Chau Re-examination and invalidity proceedings each play an important role in the patent system, offering different avenues that narrow or invalidate existing patent claims. However, a lack of clarity on how the two provisions co-exist has led to litigation which this editor believes could be avoided through legislative amendments to the American patent regime. Similar issues exist in the Canadian jurisprudence, the Canadian Patent Act does not adequately provide a framework for how this co-existence should be dealt with by the Courts.
Fishing Across the Pond
February 20, 2012 by Brian Chau Earlier this year, the Westminster Magistrates’ Court found that a young British student could be extradited to the United States to face allegations of copyright infringement. The United States Justice Department requested that he be extradited under the Extradiction Act, 2003 and the US-UK Extradition Treaty.
Is Anyone Listening?
February 3, 2012 by Brian Chau The idea of surreptitiously recording confidential conversations as material to be used against someone comes straight out of spy movies and thriller novels. The act itself is clearly reprehensible but it is surprisingly difficult to determine whether legal liability subsists. The actual practice of recording conversations without consent is governed by various criminal, privacy and telecommunications laws, but in Canada, there may also be recourse under the common law. |